Carregant...
The good, bad, and the ugly of regenerative therapies for erectile dysfunction
Erectile dysfunction (ED) is a common condition which reduces quality of life of both patients and their partners, and is a significant health care expense every year. Although phosphodiesterase type-5 inhibitors are the current first-line treatment for men with ED, they are limited by their on-dema...
Guardat en:
| Publicat a: | Transl Androl Urol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108995/ https://ncbi.nlm.nih.gov/pubmed/32257866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2019.10.06 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|